3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
29
Neoplasms
10
Brain Neoplasms
6
Neoplasm Metastasis
3
Thyroid Neoplasms
2
Thyroid Cancer, Papillary
2
Skin Neoplasms
2
Multiple Myeloma
2
Hematologic Neoplasms
2
Glioma
2
Carcinoma, Non-Small-Cell Lung
2
Thyroid Carcinoma, Anaplastic
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Oligodendroglioma
1
Nonseminomatous germ cell tumor
1
Neurofibroma, Plexiform
1
Neurocytoma
1
Neuroblastoma
1
Lymphoma
1
Leukemia, Hairy Cell
1
Histiocytosis, Langerhans-Cell
1
Glioblastoma
1
Gastrointestinal Stromal Tumors
1
Ganglioneuroma
1
Ganglioglioma
1
Fever
1
Differentiated Thyroid Cancer (DTC)
1
Colorectal Neoplasms
1
Biliary Tract Neoplasms
1
Astrocytoma
1
Interventions
Oxaliplatin
4
Leucovorin
4
Irinotecan
4
Fluorouracil
4
Capecitabine
3
Bevacizumab
3
cobimetinib
2
Tomography, X-Ray Computed
2
Surveys and Questionnaires
2
Standard of Care
2
Specimen Handling
2
Panitumumab
2
Magnetic Resonance Spectroscopy
2
Ketamine
2
Hydroxychloroquine
2
Cyclophosphamide
2
Cisplatin
2
ulixertinib
1
trifluridine tipiracil drug combination
1
trastuzumab deruxtecan
1
tivozanib
1
sodium thiosulfate
1
rucaparib
1
romiplostim
1
rilotumumab
1
regorafenib
1
pralsetinib
1
ponatinib
1
pembrolizumab
1
osimertinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Gastrointestinal Neoplasms
×
dabrafenib
×
Clear all
No trials found.